open-label trial fluoxetine obsessive-compulsive disorder Gilles Tourette syndrome Obsessive-compulsive disorder OCD association Gilles Tourette syndrome GTS major source disability Fluoxetine new antidepressant effective psychiatric patients OCD open-label trial fluoxetine mg/d GTS patients OCD week treatment patients withdrew trial due perceived lack benefit Data patients children adults neurologist months treatment significant reduction scores Leyton Obsessional Inventory adult child groups patients subjective improvement obsessions compulsions fluoxetine findings drug effective agent treatment OCD GTS patients 